SAN FRANCISCO, May 20, 2025 /PRNewswire/ — Trial Library, a technology company focused on equitable access to oncology clinical trials, announced its collaboration with Texas Oncology, one of the largest and most respected cancer care practices in the United States. This collaboration will leverage Trial Library’s innovative patient navigation platform to streamline clinical trial access for patients at Texas Oncology.
“Cancer treatment often presents significant challenges, including care coordination, socioeconomic hurdles, and logistical complexities. We hope that Trial Library will improve patient access to vital clinical trial resources.” Dr. Scott Paulson, Research Medical Director, Texas Oncology.
Trial Library’s platform is designed to alleviate these obstacles by connecting patients with tailored support, empowering them to make informed decisions, and ensuring equitable access to vital care resources. Through this relationship, Trial Library’s platform will be seamlessly integrated into Texas Oncology’s operations, offering personalized navigation to patients referred to clinical trials.
“By working with Texas Oncology, we’re advancing our mission to provide patients with streamlined access to clinical trials,” said Dr. Hala Borno, CEO and Founder of Trial Library. “Our technology simplifies clinical trial navigation and enhances the connection between patients and trial sites.”
About Trial Library
Trial Library is the leading AI-powered solution for recruitment and retention, trusted by oncologists across the United States. Learn more at www.triallibrary.com.
Media Contact:
info@triallibrary.com
SOURCE Trial Library, Inc
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…